Projects funded by the NCN

Identification of circulating biomarkers for monitoring anti-CD19 CAR-T cell treatment response in patients with aggress...

Call: PRELUDIUM 23 , Panel: NZ5

Principal investigator: Monika Szelest

Uniwersytet Medyczny w Lublinie

Identification and characterization of omics profiles in patients' serum during anti-CD19 CAR-T cell therapy

Call: PRELUDIUM 23 , Panel: NZ5

Principal investigator: Jaromir Bartosz Tomasik

Warszawski Uniwersytet Medyczny

Heterogeneity immunocompetent cells during chimeric antigen receptor T cell (CAR-T) CD19 immunotherapy.

Call: PRELUDIUM 22 , Panel: NZ6

Principal investigator: Aleksandra Maria Oszer

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Marta Krawczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell the...

Call: PRELUDIUM BIS 3 , Panel: NZ5

Principal investigator: prof. Przemysław Juszczyński

Instytut Hematologii i Transfuzjologii

Identification of surface proteins as alternate targets for CAR-T therapy against CD19-negative tumors.

Call: PRELUDIUM BIS 2 , Panel: NZ6

Principal investigator: dr hab. Magdalena Hanna Winiarska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

B regulatory cells (CD19+CD24+CD38+) in nephropathy exacerbation in the course of systemic lupus erythematosus.

Call: PRELUDIUM 13 , Panel: NZ5

Principal investigator: dr Joanna Katarzyna Kosałka-Węgiel

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski